---  
layout: startup_page  
title: "ProfoundBio"  
id: "profoundbio.com"  
permalink: "/profoundbioprofoundbio.com02132024/"  
website: "https://www.profoundbio.com"  
funding_round: "Series B"  
funding_amount: "$112M"  
investors: "Ally Bridge Group, Nextech Invest, T. Rowe Price Associates, Inc., Janus Henderson Investors, RA Capital Management, OrbiMed, Surveyor Capital, Medicxi, Logos Capital, Octagon Capital, Piper Heartland Healthcare Capital, LifeSci Venture Partners, Lilly Asia Ventures (LAV), LYFE Capital"  
about: "ProfoundBio is a clinical-stage biotechnology company developing novel antibody-drug conjugate (ADC) therapeutics for cancer patients. Their pipeline includes several ADC drug candidates targeting solid tumors and hematological malignancies, focusing on innovative approaches for improved clinical outcomes. Key programs are currently in Phase 1 and 2 clinical trials."  
markets: "Biotechnology, Oncology, Antibody-drug conjugates (ADCs), Therapeutics"  
hq: "Seattle, Washington, United States"  
founded_year: "2018"  
linkedin: "https://www.linkedin.com/company/profoundbio/"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/profoundbio"  
pitchbook: "https://pitchbook.com/profiles/company/459890-47"  

date_display: "13-Feb-2024"  
date: "2024-02-13"

# SEO Optimization  
meta_title: "ProfoundBio - Series B Funding ($112M)"  
meta_description: "ProfoundBio, ProfoundBio is a clinical-stage biotechnology company developing novel antibody-drug conjugate (ADC) therapeutics for cancer patients. Their pipeline ..."  
meta_keywords: "ProfoundBio, Biotechnology, Oncology, Antibody-drug conjugates (ADCs), Therapeutics, Series B funding"  
canonical_url: "https://startup.projectstartups.com/profoundbioprofoundbio.com02132024/"  
---